1. Home
  2. KLTO vs MITQ Comparison

KLTO vs MITQ Comparison

Compare KLTO & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • MITQ
  • Stock Information
  • Founded
  • KLTO 2019
  • MITQ N/A
  • Country
  • KLTO United States
  • MITQ United States
  • Employees
  • KLTO N/A
  • MITQ N/A
  • Industry
  • KLTO
  • MITQ Telecommunications Equipment
  • Sector
  • KLTO
  • MITQ Telecommunications
  • Exchange
  • KLTO NYSE
  • MITQ Nasdaq
  • Market Cap
  • KLTO 7.1M
  • MITQ 5.7M
  • IPO Year
  • KLTO N/A
  • MITQ 2021
  • Fundamental
  • Price
  • KLTO $0.21
  • MITQ $0.55
  • Analyst Decision
  • KLTO
  • MITQ
  • Analyst Count
  • KLTO 0
  • MITQ 0
  • Target Price
  • KLTO N/A
  • MITQ N/A
  • AVG Volume (30 Days)
  • KLTO 35.4M
  • MITQ 39.8K
  • Earning Date
  • KLTO 05-15-2025
  • MITQ 05-15-2025
  • Dividend Yield
  • KLTO N/A
  • MITQ N/A
  • EPS Growth
  • KLTO N/A
  • MITQ N/A
  • EPS
  • KLTO N/A
  • MITQ N/A
  • Revenue
  • KLTO N/A
  • MITQ $18,613,000.00
  • Revenue This Year
  • KLTO N/A
  • MITQ N/A
  • Revenue Next Year
  • KLTO N/A
  • MITQ N/A
  • P/E Ratio
  • KLTO N/A
  • MITQ N/A
  • Revenue Growth
  • KLTO N/A
  • MITQ N/A
  • 52 Week Low
  • KLTO $0.11
  • MITQ $0.50
  • 52 Week High
  • KLTO $0.99
  • MITQ $1.55
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • MITQ 40.54
  • Support Level
  • KLTO N/A
  • MITQ $0.55
  • Resistance Level
  • KLTO N/A
  • MITQ $0.57
  • Average True Range (ATR)
  • KLTO 0.00
  • MITQ 0.03
  • MACD
  • KLTO 0.00
  • MITQ -0.00
  • Stochastic Oscillator
  • KLTO 0.00
  • MITQ 5.77

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About MITQ Moving iMage Technologies Inc.

Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.

Share on Social Networks: